Phytochemical Name : Boswellia frereana extract (BFE)

Properties Information
PhytoCAT-ID PhytoCAT-1941
Phytochemical name or plant extracts Boswellia frereana extract (BFE)
PMID 30314527
Literature evidence The addition of the BFE extract quenched the HGF-enhanced migratory, angiogenic and invasive potential of these cells. Further study revealed that BFE inhibited c-Met receptor tyrosine kinase phosphorylation within these breast cancer cells.
IUPAC name NA
Phytochemicals’ class or type of plant extracts Ethanolic extract
Source of phytochemicals or plant Extracts Boswellia frereana
Geographical availability Somalia
Plant parts Gum raisin
Other cancers Breast cancer
Target gene or protein NA
Gene or Protein evidence NA
Target pathways Our findings reveal that BFE was able to significantly suppress the influence of HGF in breast cancer cell motility and invasion in vitro, through the ability of BFE to reduce HGF/c-Met signalling events.
IC50 NA
Potency These results indicate that BFE could play a novel role in the treatment of breast cancer. The addition of the BFE extract quenched the HGF-enhanced migratory, angiogenic and invasive potential of these cells. Further study revealed that BFE inhibited c-Met receptor tyrosine kinase phosphorylation within these breast cancer cells.
Cell line/ mice model BT-549 and MDA-MB-231
Additional information  we report that BFE suppresses HGF-enhanced cell migration, adhesion, vessel formation and invasion of breast cancer cells in vitro through inhibition of HGF/c-Met signalling and reduction of c-Met receptor phosphorylation.
PubChem ID NA
Additional PMIDs 30314527
Additional sources of information https://powo.science.kew.org/taxon/urn:lsid:ipni.org:names:127043-1
Safety NA